| Schedule of CODM is also Regularly Provided with Information on Significant Expenses and Cash and Cash Equivalents |
The CODM is also regularly provided with information on significant expenses and cash and cash equivalents balances, as follows: | | | Six months ended June 30, | | | Three months ended June 30, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | | | USD thousands | | | USD thousands | | | USD thousands | | | USD thousands | | | Revenues | | $ | 3,268 | | | $ | 2,591 | | | $ | 1,853 | | | $ | 1,331 | | | Less: | | | | | | | | | | | | | | | | | | Cost of revenues | | | 496 | | | | 409 | | | | 304 | | | | 213 | | | R&D expenses- excluding stock-based compensation expenses | | | 4,737 | | | | 2,825 | | | | 1,922 | | | | 1,510 | | | S&M expenses- excluding stock-based compensation expenses | | | 2,470 | | | | 2,787 | | | | 1,308 | | | | 1,277 | | | G&A expenses- excluding stock-based compensation expenses | | | 5,069 | | | | 1,772 | | | | 1,216 | | | | 884 | | | Stock based compensation expenses | | | 5,440 | | | | 2,255 | | | | 223 | | | | 866 | | | Operating loss | | | 14,944 | | | | 7,457 | | | | 3,120 | | | | 3,419 | | | Finance expenses (income) | | | (799 | ) | | | (1,716 | ) | | | 255 | | | | (992 | ) | | Taxes on income | | | 64 | | | | 19 | | | | 64 | | | | 19 | | | Net loss | | | 14,209 | | | | 5,760 | | | | 3,439 | | | | 2,446 | | | Cash and cash equivalents | | $ | 794 | | | $ | 183 | | | $ | 794 | | | $ | 183 | |
|